Supreme Court Conflicts Prevent Apartheid Ruling
2 CommentsBy Ed Silverman // May 12th, 2008 // 11:07 am
The US Supreme Court can’t intervene in an important dispute over the rights of apartheid victims to sue US corporations in US courts because four of the nine justices had to sit out the case over apparent conflicts, including stockholdings in Bristol-Myers Squibb, the Associated Press writes.
The result is that a lawsuit accusing some prominent companies of violating international law by assisting South Africa’s former apartheid government will go forward. The court’s hands were tied by federal laws that require at least six justices to hear any case before them. Short of the required number by one, the court took the only path available to it and upheld an appeals court ruling allowing the suit to proceed.
Besides the drugmaker, the justices have ties to Bank of America, Colgate-Palmolive, Credit Suisse, Exxon Mobil, Hewlett-Packard, IBM and Nestle, among nearly three dozen companies that asked the high court to step in.
The justices’ latest financial disclosures show that Chief Justice John Roberts owned H-P stock; Justice Stephen Breyer owned stock in Colgate-Palmolive, Bank of America, IBM and Nestle. Justice Samuel Alito holds shares in Exxon Mobil, which caused him to sit out the still-pending dispute over the $2.5 billion punitive damages award for the Exxon Valdez disaster, and Bristol-Myers Squibb.
Justice Anthony Kennedy does not hold stock in any affected company, but his son, Gregory, is a managing director at Credit Suisse. He sat out a case last term involving the investment bank.
Business groups, the Bush administration and the current South African government also sought the high court’s intervention. They argued that the lawsuit is damaging international relations, threatening to hurt South Africa’s economic development and punishing the companies using a fuzzy concept of aiding violations of international law.
Last year’s ruling by the 2nd US Circuit Court of Appeals in New York “allows an unprecedented and sprawling lawsuit to move forward and represents a dramatic expansion of US law,” the administration said in court papers.
Lawyers for the South Africans bringing the complaint said it was premature for the Supreme Court to get involved. The lawyers said they plan to narrow their complaint, perhaps omitting some corporations and showing more clearly how the companies assisted the apartheid government.
The case involves the Alien Tort Claims Act, an 18th-century law that allows foreigners to sue in US courts over international law violations. It was originally intended to allow foreigners to have a place to make claims against pirates, but the law has been increasingly used in the last 15 years to sue corporations for their alleged involvement in human rights abuses overseas.
The lawsuit raises sticky questions about US policy toward governments accused of repression. For example, the administration said the government may impose targeted sanctions while still allowing commerce in order to encourage reform. The suit could undermine that policy.
Source: The Associated Press
Justice in Michigan
CJ Roberts recused himself from Warner-Lambert v. Kent because he owns stock in Pfizer.
Given the fact that preemption rulings could impact the (short-term) financial interests of any pharma company, I am wondering why CJ Roberts should not also recure himself in Wyeth v. Levine, as should J. Alito given his holdings in BM Squibb.
Clearly, the policies appear to reflect only potential COIs with specific companies. But if a whole sector could be impacted, it would seem appropriate to expand the criteria for recusal.
condor
The same would seem to apply to Justice Breyer, JiM!
He seemed to hold the most health-tech/pharma of any of them, at least as of May 2007:
http://shearlingsplowed.blogspot.com/2008/05/with-fda-preemption-case-looming-on.html